- Home
- EOSE vs LMAT Comparison
EOSE vs LMAT Comparison
Compare EOSE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- LMAT
- Stock Information
- Founded
- EOSE 2008
- LMAT 1983
- Country
- EOSE United States
- LMAT United States
- Employees
- EOSE N/A
- LMAT N/A
- Industry
- EOSE Industrial Machinery/Components
- LMAT Medical/Dental Instruments
- Sector
- EOSE Miscellaneous
- LMAT Health Care
- Exchange
- EOSE Nasdaq
- LMAT Nasdaq
- Market Cap
- EOSE 2.3B
- LMAT 2.0B
- IPO Year
- EOSE N/A
- LMAT 2006
- Fundamental
- Price
- EOSE $13.69
- LMAT $86.53
- Analyst Decision
- EOSE Buy
- LMAT Buy
- Analyst Count
- EOSE 5
- LMAT 6
- Target Price
- EOSE $7.90
- LMAT $99.67
- AVG Volume (30 Days)
- EOSE 21.2M
- LMAT 184.3K
- Earning Date
- EOSE 11-04-2025
- LMAT 10-30-2025
- Dividend Yield
- EOSE N/A
- LMAT 0.92%
- EPS Growth
- EOSE N/A
- LMAT 22.69
- EPS
- EOSE N/A
- LMAT 2.05
- Revenue
- EOSE $33,800,000.00
- LMAT $234,639,000.00
- Revenue This Year
- EOSE $857.58
- LMAT $16.32
- Revenue Next Year
- EOSE $225.49
- LMAT $8.62
- P/E Ratio
- EOSE N/A
- LMAT $42.21
- Revenue Growth
- EOSE 128.49
- LMAT 14.11
- 52 Week Low
- EOSE $2.06
- LMAT $71.42
- 52 Week High
- EOSE $15.19
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- EOSE 84.84
- LMAT 40.07
- Support Level
- EOSE $9.78
- LMAT $84.41
- Resistance Level
- EOSE $15.18
- LMAT $89.48
- Average True Range (ATR)
- EOSE 1.00
- LMAT 2.56
- MACD
- EOSE 0.30
- LMAT -0.21
- Stochastic Oscillator
- EOSE 78.38
- LMAT 28.64
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.